Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Abiraterone ACetate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01543776
What this trial is testing

Food Effect Study of Abiraterone Acetate for Treatment of Patients With Castration-Resistant Prostate Cancer

Who this might be right for
Castration-resistant Prostate CancerStage IV Prostate Cancer
University of Chicago 72
Testing effectiveness (Phase 2)Study completedNCT03279250
What this trial is testing

Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage IIB Prostate Cancer AJCC v8Stage IIC Prostate Cancer AJCC v8+2 more
M.D. Anderson Cancer Center 86
Not applicableStudy completedNCT01858441
What this trial is testing

Pharmacogenetic Study in Castration-resistant Prostate Cancer Patients Treated With Abiraterone Acetate

Who this might be right for
Pharmacogenetic Study
Centre Antoine Lacassagne 148
Testing effectiveness (Phase 2)WithdrawnNCT03548246
What this trial is testing

Androgen Reduction in Congenital Adrenal Hyperplasia

Who this might be right for
Congenital Adrenal Hyperplasia
University of Texas Southwestern Medical Center
Early research (Phase 1)Study completedNCT01186484
What this trial is testing

Phase 1 Study of Abiraterone Acetate in Castration-resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Janssen Pharmaceutical K.K. 27
Testing effectiveness (Phase 2)Ended earlyNCT04458311
What this trial is testing

Abiraterone Acetate in Combination With Tildrakizumab

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Institute of Cancer Research, United Kingdom 13
Testing effectiveness (Phase 2)Study completedNCT02928432
What this trial is testing

SWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With Abiraterone

Who this might be right for
Prostate Cancer
Centro Nacional de Investigaciones Oncologicas CARLOS III 26
Testing effectiveness (Phase 2)Ended earlyNCT05689021
What this trial is testing

CJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
Mayo Clinic 8
Early research (Phase 1)Study completedNCT01655147
What this trial is testing

Evaluate the Effect of Rifampicin on the Pharmacokinetics of Abiraterone in Healthy Male Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 19
Testing effectiveness (Phase 2)Study completedNCT02077634
What this trial is testing

Trial of Abiraterone Acetate Plus LHRH-therapy Versus Abiraterone Acetate Sparing LHRH-therapy in Patients With Progressive Chemotherapy-naïve Castration-resistant Prostate Cancer (SPARE)

Who this might be right for
Prostate Cancer
Universität des Saarlandes 68
Large-scale testing (Phase 3)Study completedNCT01695135
What this trial is testing

Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapy

Who this might be right for
Prostate Neoplasms
Janssen Research & Development, LLC 214
Not applicableApproved For MarketingNCT01217697
What this trial is testing

Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer

Who this might be right for
Prostate NeoplasmsGenital Neoplasms, MaleUrogenital Neoplasms+1 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Early research (Phase 1)Study completedNCT01678573
What this trial is testing

Evaluate the Pharmacokinetics of Abiraterone in Healthy Chinese Male Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT02960022
What this trial is testing

Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Who this might be right for
Prostate Cancer
Astellas Pharma Global Development, Inc. 900
Large-scale testing (Phase 3)Looking for participantsNCT03851640
What this trial is testing

A Trial Evaluating the Efficacy and Safety of HC-1119 Soft Capsules in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Who this might be right for
MCRPC
Hinova Pharmaceuticals Inc. 417
Early research (Phase 1)Study completedNCT01588782
What this trial is testing

Assess the Effect of Ketoconazole on the Pharmacokinetics of Abiraterone Following Administration of Abiraterone Acetate Tablets in Healthy Adult Men

Who this might be right for
Healthy Volunteers
Janssen Research & Development, LLC 20
Testing effectiveness (Phase 2)Study completedNCT04862091
What this trial is testing

Comparative Study of Abiraterone Acetate Tablets (I) or ZYTIGA® in Patients With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Jiangsu HengRui Medicine Co., Ltd. 69
Testing effectiveness (Phase 2)Ended earlyNCT01735396
What this trial is testing

Abiraterone Acetate Trial in African American Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Icahn School of Medicine at Mount Sinai 11
Testing effectiveness (Phase 2)WithdrawnNCT03173859
What this trial is testing

Efficacy of Rotations Between Abiraterone Acetate and Apalutamide in mCRPC Patients

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
University of Athens
Testing effectiveness (Phase 2)Study completedNCT02867020
What this trial is testing

Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels

Who this might be right for
Prostate Cancer
Latin American Cooperative Oncology Group 128
Next Page